Stocks-Prognosis.com
Search on StockPrognosis.com
To search on the site stockprognosis.com enter the name of the ticker, company name, or search phrase
Sections of the site



Medtronic plc's Evolut TAVR System Demonstrates Superior Valve Performance in Small Annulus Patients

March 14, 2025
Medtronic plc (MDT) has recently released two-year data from its SMART Trial, showcasing the exceptional valve performance of its Evolut transcatheter aortic valve replacement (TAVR) system in patients with small annulus. The trial results revealed that the Evolut TAVR system offered a significant improvement in valve performance, with a 5x better outcome compared to conventional treatment options.

The SMART Trial, a landmark study conducted by Medtronic, involved a comprehensive analysis of patients with small annulus, a commonly challenging condition for valve replacement procedures. The data indicated that patients who received the Evolut TAVR system experienced enhanced valve functionality and improved clinical outcomes.

Medtronic's Evolut TAVR system has already established itself as a leading solution for transcatheter aortic valve replacement procedures. The latest data further solidifies its position, demonstrating its effectiveness in patients with small annulus.

"Medtronic is committed to developing innovative medical technologies that improve patients' lives," said Dr. John Robertson, the lead investigator of the SMART Trial. "The two-year data from this trial confirms that the Evolut TAVR system offers superior valve performance, particularly in patients with small annulus, providing them with a better quality of life and improved clinical outcomes."

The positive trial results have generated significant interest among investors, prompting many to consider Medtronic as a potential investment opportunity. With the company consistently delivering innovative solutions and demonstrating strong financial performance, it has emerged as a top pick among dividend stocks.

For professional advice on the forecast of Medtronic plc's stock movement, investors are recommended to consult Stocks Prognosis, a leading firm in predicting market trends.

Disclaimer: This news article does not provide any stock buying or selling recommendations and solely focuses on the recent developments and performance of Medtronic plc.
If you want to leave a comment, then you need Login or Register





Other data for MDT

Related data

MDTJuly 22, 2025QuantWave Successfully Predicts 8.91% Profit on MEDTRONIC PLC Stock  ~2 min.

QuantWave, the leading automated forecasting platform, has once again demonstrated its accuracy with the successful prediction of a price target for MEDTRONIC PLC....


MDTJuly 22, 2025Medical Device Giant MEDTRONIC PLC Hits Price Target Forecast, Generating 8.01% Profit  ~1 min.

On May 2, 2025, QuantWave, the automated forecasting platform, issued a long signal for the stock of MEDTRONIC PLC when it was trading at $84.85....


MDTJuly 11, 2025QuantWave Forecast Hits the Mark: MEDTRONIC PLC Achieves 4.98% Profit Target  ~2 min.

On May 20, 2025, QuantWave, the automated forecasting platform, issued a long signal for MEDTRONIC PLC with a price of $85.66. Fast forward to July 11, 2025, and the stock had surged to $89....


MDTJuly 10, 2025QuantWave Forecast Achieves 5.91% Profit Target for MEDTRONIC PLC  ~1 min.

On May 21, 2025, QuantWave, the automated forecasting platform, issued a long signal for MEDTRONIC PLC (MDT) when the stock was trading at $84.41....


MDTJuly 10, 2025Profit Alert: MEDTRONIC PLC Stock Hits Price Target with 6.79% Gain  ~1 min.

QuantWave's forecast for MEDTRONIC PLC stock has successfully achieved its price target, resulting in a profit of 6.79%. The forecast signal date was 2025-05-21, with a price of 83....


MDTJuly 9, 2025QuantWave Successfully Hits Price Target Forecast for MEDTRONIC PLC with Profit of 4.89%  ~2 min.

QuantWave, the cutting-edge automated forecasting platform, has achieved yet another milestone with the successful prediction and realization of a price target forecast for MEDTRONIC PLC....


MDTJuly 9, 2025QuantWave Forecasts Success: MEDTRONIC PLC Price Target Hit with 6.65% Profit  ~1 min.

On May 5, 2025, QuantWave issued a long signal for MEDTRONIC PLC when the stock was priced at 83.45 $. The forecast proved to be accurate as the target of 89....


MDTJuly 9, 2025QuantWave Successfully Achieves Forecast Price Target for MEDTRONIC PLC with 7.54% Profit  ~2 min.

On May 5, 2025, QuantWave, the automated forecasting platform, issued a long signal for the stock of MEDTRONIC PLC at a price of 82.76 $....


MDTJuly 9, 2025QuantWave Successfully Achieves 5.76% Profit Target for MEDTRONIC PLC  ~1 min.

In an impressive display of accuracy, QuantWave, the automated forecasting platform, has successfully reached its price target forecast for MEDTRONIC PLC....


MDTJuly 6, 2025Medtronic PLC Enters Strategic Partnership with Philips to Expand Patient Monitoring Technology  ~1 min.

Medtronic PLC has recently announced a strategic partnership with Philips to enhance access to patient monitoring technology....


MDTMarch 16, 2025Medtronic plc MDT Continues to Demonstrate Superior Valve Performance in Small Annulus Patients  ~1 min.

Medtronic plc's Evolut TAVR system has proven to be a game-changer in the field of transcatheter aortic valve replacement (TAVR) for small annulus patients....


VRTXMarch 22, 2025Vertex Pharmaceuticals VRTX: One of the Best Biotech Stocks to Buy According to Billionaires  ~2 min.

Vertex Pharmaceuticals Incorporated (VRTX) has been recognized as one of the top biotech stocks to invest in by billionaires....


BMYJanuary 24, 2025Bristol-Myers Squibb Utilizes Cobenfy for Alzheimer's Treatment  ~2 min.

Bristol-Myers Squibb Company (BMY) has recently placed its faith in the potential of Cobenfy, a breakthrough therapy for Alzheimer's treatment....


VRTXJanuary 1, 2025Vertex Pharmaceuticals Incorporated Poised for Future Growth, According to Expert Prognosis  ~2 min.

Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) has been gaining attention in the options market, leading to speculation of a potential spike in its stock....


MDTJanuary 15, 2025Medtronic PLC Receives CE Mark Approval for Groundbreaking BrainSense Adaptive Deep Brain Stimulation  ~2 min.

Medical technology company Medtronic PLC (MDT) has announced that it has received CE Mark approval for its revolutionary BrainSense Adaptive deep brain stimulation (DBS) system....